Delcath Systems Company
Delcath Systems and its proprietary targeted drug delivery system are at the forefront of the regional treatment of cancer.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
New York, New York, United States
Founded Date:
1987
Employees Number:
11-50
Funding Status:
IPO
Estimated Revenue:
Less than $1M
Register and Claim Ownership